1. Home
  2. XP vs BIO Comparison

XP vs BIO Comparison

Compare XP & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XP Inc.

XP

XP Inc.

N/A

Current Price

$18.88

Market Cap

8.4B

Sector

Finance

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$382.03

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
XP
BIO
Founded
2001
1952
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
8.0B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
XP
BIO
Price
$18.88
$382.03
Analyst Decision
Strong Buy
Buy
Analyst Count
6
4
Target Price
$23.17
$339.75
AVG Volume (30 Days)
4.6M
255.5K
Earning Date
05-19-2026
04-30-2026
Dividend Yield
0.98%
N/A
EPS Growth
N/A
142.61
EPS
N/A
N/A
Revenue
N/A
$2,583,200,000.00
Revenue This Year
$19.00
$2.74
Revenue Next Year
$13.64
$3.20
P/E Ratio
$11.42
N/A
Revenue Growth
N/A
0.65
52 Week Low
$14.80
$236.73
52 Week High
$23.13
$396.23

Technical Indicators

Market Signals
Indicator
XP
BIO
Relative Strength Index (RSI) 69.17 71.34
Support Level $18.50 $287.41
Resistance Level $20.16 N/A
Average True Range (ATR) 0.62 10.77
MACD 0.24 -0.13
Stochastic Oscillator 97.77 72.81

Price Performance

Historical Comparison
XP
BIO

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: